|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
14
|
|
pubmed:dateCreated |
2003-4-3
|
|
pubmed:abstractText |
Aldosterone blockade reduces mortality and morbidity among patients with severe heart failure. We conducted a double-blind, placebo-controlled study evaluating the effect of eplerenone, a selective aldosterone blocker, on morbidity and mortality among patients with acute myocardial infarction complicated by left ventricular dysfunction and heart failure.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1533-4406
|
|
pubmed:author |
pubmed-author:BittmanRichardR,
pubmed-author:Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and...,
pubmed-author:GatlinMarjorieM,
pubmed-author:HurleySteveS,
pubmed-author:KleimanJayJ,
pubmed-author:MartinezFelipeF,
pubmed-author:NeatonJamesJ,
pubmed-author:PittBertramB,
pubmed-author:RemmeWillemW,
pubmed-author:RonikerBarbaraB,
pubmed-author:ZannadFaiezF
|
|
pubmed:copyrightInfo |
Copyright 2003 Massachusetts Medical Society
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
3
|
|
pubmed:volume |
348
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1309-21
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:12668699-Aged,
pubmed-meshheading:12668699-Aldosterone Antagonists,
pubmed-meshheading:12668699-Blood Pressure,
pubmed-meshheading:12668699-Death, Sudden, Cardiac,
pubmed-meshheading:12668699-Double-Blind Method,
pubmed-meshheading:12668699-Female,
pubmed-meshheading:12668699-Heart Failure,
pubmed-meshheading:12668699-Hospitalization,
pubmed-meshheading:12668699-Humans,
pubmed-meshheading:12668699-Male,
pubmed-meshheading:12668699-Middle Aged,
pubmed-meshheading:12668699-Myocardial Infarction,
pubmed-meshheading:12668699-Potassium,
pubmed-meshheading:12668699-Receptors, Aldosterone,
pubmed-meshheading:12668699-Spironolactone,
pubmed-meshheading:12668699-Survival Analysis,
pubmed-meshheading:12668699-Ventricular Dysfunction, Left
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.
|
|
pubmed:affiliation |
University of Michigan, Ann Arbor, USA. bpitt@umich.edu
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
